European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Apceth GmbH & Co. KG, Munich, Germany✝︎

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Apceth GmbH & Co. KG

Identification

Ut
District Court of Munich HRA 91052
EUID
DED2601V.HRA91052

Address

München, Germany

Corporate purpose

Isolation and use of adult stem cells from donors and patients for therapy optimization in the field of therapeutic and regenerative cell therapy, as well as the related and related research, in order to ultimately obtain approval for a human medical treatment that can then be commercialized.

Financial performance

History

Network

Loading network

Legal Structure

Last legal representatives (1)
This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Financials

Key Performance Indicators: Financial (0) · Mktg & Tech (5)

The following indicators are on file for this company: Trademarks

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Publications

4 Apr 2025
Word figurative mark: “apceth applied cell therapy“
5 Dec 2024 via ATHOS Beteiligung GmbH also 27/10/2023, 26/10/2023
Shareholder: ATHOS Beteiligung GmbH
27 Jul 2023
Wordmark: “apceth“
4 May 2022 via Santo Holding (Deutschland) GmbH also 14/09/2021, 27/03/2020, 07/03/2019, 20/02/2018, 04/04/2016, 09/10/2014, 28/03/2014, 20/09/2013, 08/06/2012, 12/03/2012, 24/05/2011, 29/04/2010, 15/04/2010, 30/06/2009, 30/06/2009, 30/06/2009
Shareholder: Santo Holding (Deutschland) GmbH
24 Apr 2020 via JunctuCell Biomed Manufacturing GmbH also 23/04/2020
No longer Control, No longer Profit Transfer: Apceth Biopharma Manufacturing Company GmbH
30 Oct 2019
Patent: Genetically Modified Mesenchymal Stem Cells Expressing an Immune Response-Stimulating Cytokine to Attract and/or Activate Immune Cells
24 Jul 2019
Patent: Genetically Modified Mesenchymal Stem Cell Expressing Klotho
3 Apr 2019 via MINARIS Regenerative Medicine GmbH also 02/04/2019
No longer Control, No longer Profit Transfer: Apceth Biopharma GmbH
19 Mar 2019
The spin-off was entered in the register of the registered office of the transferring legal entity on 13.03.2019 (see …
14 Mar 2019 via MINARIS Regenerative Medicine GmbH also 13/03/2019
Break-up: Apceth Biopharma GmbH
9 Mar 2019
Break-up: Apceth Biopharma GmbH
27 Feb 2019
Patent: Genetically Modified Mesenchymal Stem Cells Expressing Alpha-1 Antitrypsin (AAT)
7 Mar 2018
No longer Authorized signatory (ppa) (2)
1 Nov 2017
Patent: Expansion Medium for CD34-Negative Stem Cells
5 Oct 2017
Patent: Mesenchymale Stammzellen zur Verbesserung der Antitumorwirkung einer Immuntherapie
16 Aug 2017
Patent: Protection of the Vascular Endothelium From Immunologically Mediated Cytotoxic Reactions with Human CD34-Negative Progenitor Cells
10 May 2017
Patent: Engineered Mesenchymal Stem Cells and Method of Using Same to Treat Tumors
1 Feb 2017
Patent: Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie
Year 2016 in Dpmap
6 patent filings: Klotho Exprimierende Genetisch Modifizierte Mesenchymale Stammzelle …
25 Aug 2016
Patent: Mesenchymal Stem Cells for the Treatment of Metastatic Liver Disease
5 Aug 2016
Spin-off: Apceth Biopharma GmbH
2 Aug 2016 via MINARIS Regenerative Medicine GmbH also 01/08/2016
Spin-off: Apceth Biopharma GmbH
18 Mar 2016
Patent: Hypoxia-Induced Expression of Therapeutic Proteins in Mesenchymal Stem Cells
8 Mar 2016 via JunctuCell Biomed Manufacturing GmbH also 07/03/2016
Control, Profit Transfer: Apceth Forschungs-GmbH
29 Dec 2015
Authorized signatory (ppa) (2)
9 Nov 2015
Annual financial statements for the financial year from 01.01.2014 to 31.12.2014
4 Sept 2015 via MINARIS Regenerative Medicine GmbH also 03/09/2015
Control, Profit Transfer: Apceth Biopharma GmbH
18 Aug 2015
Patent: Genetically Modified Mesenchymal Stem Cells Expressing an Immune Response-Stimulating Cytokine to Attract and/or Activate Immune Cells
29 Apr 2015 via Santo Holding (Deutschland) GmbH also 03/03/2011
Shareholding: Santo Holding (Deutschland) GmbH
23 Jul 2014
Patent: Genetically Modified CD34 Negative Mesenchymal Stem Cells for Tumour Treatment
10 Jul 2013
Patent: Mesenchymal CD34- Stem Cells for use in Wound Healing Gene Therapy
9 Jan 2013
Address
19 Dec 2012
Patent: Mesenchymal CD34- Stem Cells for use in Diabetes Gene Therapy
13 Nov 2012
Patent: Polymer Modified Substrates, Their Preparation and Uses Thereof
1 Jul 2011 in Fk
Public funding (€212,943): Stem cell generation and manipulation by nanoparticle mediated gene transfer for the safe clinical application of gene-modified cells (NanoGene) - Subproject: Cancer …
26 Jan 2011
Registered ex officio in accordance with Article 65 EGHGB: Business address: Rosenheimer Platz 6, 81669 Munich
21 Oct 2010
Patent: Technisch Hergestellte Mesenchym-Stammzellen und Verfahren zu Ihrer Verwendung BEI der Behandlung von Tumoren
1 Jul 2010 in Fk
Public funding (€1,952,446): Leading-Edge Cluster m4, Personalized Medicine Network: Stem Cell-Based Therapies for the Treatment of Malignant and Non-Malignant Diseases (PM5)
29 Jul 2009
Patent: Chemokine-Mucin Fusions Linked to Glycosylphosphatidylinositol (GPI)-Anchors in Tissue Regeneration and as Tumour Immune Adjuvants
30 Jun 2009 via Santo Holding GmbH
Shareholder: Santo Holding GmbH
20 May 2008
Patent: CD34neg Stem Cells for the Treatment of Gastrointestinal Disorders
24 Oct 2007
Reg­is­tra­tion · General partner: Apceth Verwaltungs GmbH · Corporate Purpose
There are no publications matching your search.

Mentions

9 Nov 2018 in Hrdk also 28/07/2015
MINARIS Regenerative Medicine GmbH: “Liste der Gesellschafter“
29 Jan 2016 in Hrdk
JunctuCell Biomed Manufacturing GmbH: “Liste der Gesellschafter“
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.